TCL Archive In Brief: ACS Appoints Directors For Government Relations And Grassroots Development April 25, 1997
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel. October 20, 2000